Novartis Opens Probe Into Whistleblower's Kickback Claims

Law360, New York (August 14, 2013, 7:55 PM ET) -- Novartis AG said Wednesday that it had launched an internal probe after one of its former employees in China filed a complaint alleging that the company had paid kickbacks and encouraged doctors to make off-label prescriptions to drive sales of cancer drug Sandostatin.

According to the Swiss drugmaker, its former employee had filed claims with her local labor authority after resigning from the company, which had spurred its internal Business Practices Office to investigate, “as is our practice,” and ensure compliance with both Chinese law and...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required